Systemic availability of levonorgestrel after single oral administration of a norgestimate-containing combination oral contraceptive to 12 young women
- 1 March 1994
- journal article
- Published by Elsevier in Contraception
- Vol. 49 (3) , 255-263
- https://doi.org/10.1016/0010-7824(94)90043-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptivesActa Obstetricia et Gynecologica Scandinavica, 1992
- Comparative contraceptive efficacy and mechanism of action of the norgestimate‐containing triphasic oral contraceptiveActa Obstetricia et Gynecologica Scandinavica, 1992
- Metabolism of the oral contraceptive steroids ethynylestradiol and norgestimate by normal (Huma 7) and malignant (MCF-7 and ZR-75-1) human breast cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Metabolism of norgestimate by human gastrointestinal mucosa and liver microsomes in vitroThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Pharmacologic and pharmacokinetic characteristics of norgestimate and its metabolitesAmerican Journal of Obstetrics and Gynecology, 1990
- Supportive European Data on a New Oral Contraceptive Containing NorgestimateActa Obstetricia et Gynecologica Scandinavica, 1990
- Biotransformation of norgestimate in womenContraception, 1984
- The pharmacokinetics of levonorgestrel and ethynylestradiol in women — Studies with ovran and ovranetteContraception, 1981
- Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in womenContraception, 1978
- The conversion of -norgestrel-3-oxime-17-acetate to -norgestrel in female rhesus monkeysContraception, 1977